Neptune Wellness Solutions has completed a radical refocus of the company with the announcement of its entry into the hemp/CBD market in the United States.
CBD firm Bod Australia has embarked on a first-of-its-kind clinical trial on medical cannabis for Tourette syndrome patients, while continuing to expand its supplements business in countries with a more conducive regulatory environment than its home market.
The hemp/CBD industry is being threatened by so-called synthetic cannabinoids that are flooding the market, attendees at a recent botanicals conference were told.
“Our board sees wisdom in admitting as CRN members those CBD companies who are playing by [the] rules," says CRN president and CEO
Having some companies specializing in the still-not-legal dietary ingredient CBD join CRN will help the trade group as it looks to “help FDA, or Congress, craft those regulations,” said Andrew Shao, CRN’s senior vice president of scientific and regulatory...
Setting firm commodity prices will be one brick in the wall of a fully legitimized hemp industry. One company has set about doing so with a proprietary trading platform.
FDA has reiterated its enforcment stance on CBD and hemp products, has updated a Q&A document on the subject and has specified what kind of information it is seeking in the runup to a public meeting on the subject in May, all as part of documents...
FDA has sent three companies marketing CBD products warning letters over disease claims. The warnings are the first issued under FDA’s de facto ‘enforcement discretion’ policy, which will be discussed at a meeting on CBD set for the end of May.
The hemp industry is advancing so rapidly that the timeline of decades of other sectors is being compressed into just years, attendees at a recent trade show were told.
The world of hemp and CBD products sits at a critical moment in its history, much as the dietary supplement industry did a quarter century ago, according to one of the experts who was there at the birth of the industry.
The American Herbal Products Association (AHPA) has adopted a Guidance Policy for dietary supplement and food products that contain hemp and hemp-derived cannabidiol (CBD).
The European cannabidol (CBD) market is set to blossom over the next four years, according to a market intelligence firm, who also predict that Germany’s growth will outpace that of other EU countries.
Evidence presented at the Novel Food Commission meeting this week has triggered a rethink for authorities over the decision to classify Cannabidiol (CBD) as a novel food (NF).
With growth “like a rocket ship”, a new range of hemp-CBD products, and a continued commitment to keto and protein, “2019 is going to be a great year”, says Ancient Nutrition product innovator and founder, Jordan Rubin.
